Arbutus Biopharma (ABUS) Institutional Ownership

$4.35 +0.09 (+2.11%)

Closing price 04:00 PM Eastern

Extended Trading

$4.34 0.00 (-0.11%)

As of 07:45 PM Eastern

Compare

Current Institutional Ownership Percentage: 43.79%
Number of Institutional Buyers (last 12 months): 85
Total Institutional Inflows (last 12 months): $105.19M

Number of Institutional Sellers (last 12 months): 46
Total Institutional Outflows (last 12 months): $40.58M

Get ABUS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arbutus Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/28/2026	Avidity Partners Management LP	125,000	$562K	0.1%	N/A	0.063%
5/19/2026	Front Row Advisors LLC	110,500	$497K	0.2%	+952.4%	0.056%
5/19/2026	Bank of America Corp DE	1,683,628	$7.58M	0.0%	-8.1%	0.852%
5/18/2026	ADAR1 Capital Management LLC	3,133,175	$14.10M	0.8%	-42.1%	1.586%
5/18/2026	Rubric Capital Management LP	6,626,389	$29.82M	0.3%	+320.6%	3.354%
5/16/2026	The Manufacturers Life Insurance Company	42,429	$191K	0.0%	-10.6%	0.021%
5/16/2026	Quantinno Capital Management LP	48,715	$219K	0.0%	-10.9%	0.025%
5/15/2026	Rangeley Capital LLC	500,000	$2.25M	2.1%	-40.5%	0.253%
5/14/2026	Inceptionr LLC	32,580	$147K	0.0%	+14.6%	0.017%
5/5/2026	Bank of New York Mellon Corp	379,373	$1.71M	0.0%	-2.2%	0.193%
Get the Latest News and Ratings for ABUS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter.
5/4/2026	Principal Financial Group Inc.	10,977	$49K	0.0%	N/A	0.006%
4/28/2026	Abel Hall LLC	20,073	$90K	0.0%	-34.8%	0.010%
4/16/2026	SG Americas Securities LLC	79,033	$356K	0.0%	+89.8%	0.040%
2/19/2026	Invesco Ltd.	247,254	$1.19M	0.0%	+17.9%	0.129%
2/18/2026	Mercer Global Advisors Inc. ADV	45,120	$217K	0.0%	+15.8%	0.023%
2/18/2026	Virtus Investment Advisers LLC	56,483	$272K	0.1%	+77.7%	0.029%
2/18/2026	Wellington Management Group LLP	474,361	$2.28M	0.0%	-7.7%	0.247%
2/18/2026	Saba Capital Management L.P.	347,885	$1.67M	0.0%	-48.7%	0.181%
2/18/2026	Oxford Asset Management LLP	21,632	$104K	0.0%	N/A	0.011%
2/18/2026	Man Group plc	120,821	$581K	0.0%	+52.2%	0.063%
2/18/2026	Irenic Capital Management LP	59,853	$288K	0.0%	N/A	0.031%
2/18/2026	Balyasny Asset Management L.P.	141,646	$681K	0.0%	+31.6%	0.074%
2/17/2026	ADAR1 Capital Management LLC	5,415,109	$26.05M	1.9%	+86.5%	2.816%
2/17/2026	Abel Hall LLC	30,779	$148K	0.0%	N/A	0.016%
2/17/2026	Lazard Asset Management LLC	67,840	$326K	0.0%	N/A	0.035%
2/17/2026	Amundi	11,878	$57K	0.0%	N/A	0.006%
2/17/2026	Price T Rowe Associates Inc. MD	89,216	$430K	0.0%	+7.5%	0.046%
2/17/2026	Osaic Holdings Inc.	1,348,224	$6.49M	0.0%	+0.7%	0.701%
2/17/2026	Adage Capital Partners GP L.L.C.	4,339,941	$20.88M	0.0%	-13.5%	2.257%
2/17/2026	California State Teachers Retirement System	144,110	$693K	0.0%	+9.6%	0.075%
2/17/2026	State of Wisconsin Investment Board	92,769	$446K	0.0%	+621.2%	0.048%
2/17/2026	ExodusPoint Capital Management LP	30,503	$147K	0.0%	-63.0%	0.016%
2/17/2026	Royal Bank of Canada	65,687	$316K	0.0%	-72.3%	0.034%
2/16/2026	Squarepoint Ops LLC	28,775	$138K	0.0%	-57.4%	0.015%
2/16/2026	Verition Fund Management LLC	20,000	$96K	0.0%	N/A	0.010%
2/16/2026	Barclays PLC	356,684	$1.72M	0.0%	+25.4%	0.185%
2/13/2026	The Manufacturers Life Insurance Company	47,459	$228K	0.0%	-12.4%	0.025%
2/13/2026	Hudson Bay Capital Management LP	675,000	$3.25M	0.0%	-15.6%	0.351%
2/13/2026	Morgan Stanley	26,702,776	$128.44M	0.0%	+9.2%	13.885%
2/13/2026	Rafferty Asset Management LLC	117,032	$563K	0.0%	+120.8%	0.061%
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes
2/13/2026	Charles Schwab Investment Management Inc.	1,562,265	$7.51M	0.0%	+22.5%	0.812%
2/13/2026	State Street Corp	5,908,211	$28.42M	0.0%	+44.2%	3.072%
2/13/2026	Dynamic Technology Lab Private Ltd	25,779	$124K	0.0%	N/A	0.013%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	890,898	$4.29M	0.0%	N/A	0.463%
2/13/2026	Wells Fargo & Company MN	167,021	$803K	0.0%	+75.0%	0.087%
2/12/2026	MetLife Investment Management LLC	73,236	$352K	0.0%	-16.6%	0.038%
2/12/2026	Cibc World Markets Corp	10,015	$48K	0.0%	N/A	0.005%
2/12/2026	EntryPoint Capital LLC	75,607	$364K	0.1%	+161.9%	0.039%
2/12/2026	Ensign Peak Advisors Inc	27,600	$133K	0.0%	-38.7%	0.014%
2/12/2026	AlphaCentric Advisors LLC	47,925	$231K	0.2%	N/A	0.025%
2/12/2026	Campbell & CO Investment Adviser LLC	113,113	$544K	0.0%	+54.3%	0.059%
2/12/2026	Swiss National Bank	283,400	$1.36M	0.0%	+2.6%	0.147%
2/11/2026	Inceptionr LLC	28,418	$137K	0.0%	N/A	0.015%
2/11/2026	T3 Companies LLC	34,000	$164K	0.2%	N/A	0.018%
2/11/2026	Deutsche Bank AG	140,198	$674K	0.0%	+6.4%	0.073%
2/11/2026	Los Angeles Capital Management LLC	46,520	$225K	0.0%	N/A	0.024%
2/11/2026	Two Seas Capital LP	12,589,158	$60.55M	1.2%	+14.5%	6.546%
2/11/2026	State of Wyoming	15,421	$74K	0.0%	N/A	0.008%
2/10/2026	CIBC Asset Management Inc	14,382	$69K	0.0%	N/A	0.007%
2/10/2026	Goldman Sachs Group Inc.	738,580	$3.55M	0.0%	-66.0%	0.384%
2/10/2026	Intech Investment Management LLC	70,563	$339K	0.0%	+48.6%	0.037%
2/9/2026	Geode Capital Management LLC	3,677,307	$17.69M	0.0%	+0.3%	1.912%
2/6/2026	ProShare Advisors LLC	36,161	$174K	0.0%	+10.5%	0.019%
2/3/2026	Mitsubishi UFJ Asset Management Co. Ltd.	54,066	$258K	0.0%	-26.6%	0.028%
2/3/2026	SBI Securities Co. Ltd.	29,625	$142K	0.0%	-31.0%	0.015%
1/28/2026	Arizona State Retirement System	39,962	$192K	0.0%	-5.7%	0.021%
1/27/2026	Zurcher Kantonalbank Zurich Cantonalbank	128,315	$617K	0.0%	+27.9%	0.067%
1/26/2026	PFG Investments LLC	11,000	$53K	0.0%	-18.5%	0.006%
1/20/2026	Wealth Management Associates Inc.	127,870	$615K	0.2%	+13.3%	0.066%
1/9/2026	SG Americas Securities LLC	41,638	$200K	0.0%	+78.1%	0.022%
1/1/2026	JPMorgan Chase & Co.	98,229	$446K	0.0%	+14.1%	0.051%
12/15/2025	Hudson Bay Capital Management LP	800,000	$3.63M	0.0%	-17.1%	0.416%
11/21/2025	CIBC Bancorp USA Inc.	16,138	$73K	0.0%	N/A	0.008%
11/17/2025	Woodline Partners LP	2,165,602	$9.83M	0.0%	-13.3%	1.130%
11/17/2025	Two Seas Capital LP	10,991,261	$49.90M	0.8%	+5.2%	5.734%
11/17/2025	Voleon Capital Management LP	10,403	$47K	0.0%	N/A	0.005%
11/17/2025	Sherbrooke Park Advisers LLC	37,073	$168K	0.1%	+71.4%	0.019%
11/17/2025	Qube Research & Technologies Ltd	215,041	$976K	0.0%	-41.6%	0.112%
11/17/2025	Mercer Global Advisors Inc. ADV	38,959	$177K	0.0%	+9.2%	0.020%
11/17/2025	Millennium Management LLC	528,340	$2.40M	0.0%	+5.8%	0.276%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	73,806	$335K	0.0%	-15.5%	0.039%
11/17/2025	Jain Global LLC	26,000	$118K	0.0%	N/A	0.014%
11/17/2025	Foursixthree Capital LP	1,978,975	$8.99M	2.5%	-22.6%	1.032%
11/17/2025	Bank of America Corp DE	1,450,822	$6.59M	0.0%	+21.1%	0.757%
11/17/2025	Alliancebernstein L.P.	143,870	$653K	0.0%	+19.7%	0.075%
11/14/2025	Man Group plc	79,374	$360K	0.0%	+103.5%	0.041%
11/14/2025	ADAR1 Capital Management LLC	2,903,226	$13.18M	1.2%	+2.7%	1.514%
11/14/2025	Brooklyn Investment Group	14,163	$64K	0.0%	+3,485.6%	0.007%
11/14/2025	Squarepoint Ops LLC	67,611	$307K	0.0%	+184.0%	0.035%
11/14/2025	Quinn Opportunity Partners LLC	514,513	$2.34M	0.2%	+10.8%	0.268%
The REAL Reason Trump is Invading Iran (Ad) For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
11/13/2025	Kennedy Capital Management LLC	505,099	$2.29M	0.1%	+12.4%	0.263%
11/13/2025	Arrowstreet Capital Limited Partnership	159,118	$722K	0.0%	N/A	0.083%
11/13/2025	UBS Group AG	774,594	$3.52M	0.0%	+307.2%	0.404%
11/13/2025	BNP Paribas Financial Markets	89,899	$408K	0.0%	+60.7%	0.047%
11/13/2025	Russell Investments Group Ltd.	22,739	$103K	0.0%	+186.0%	0.012%
11/12/2025	Barclays PLC	284,330	$1.29M	0.0%	-30.1%	0.148%
11/12/2025	Rafferty Asset Management LLC	53,008	$241K	0.0%	-40.1%	0.028%
11/12/2025	Western Standard LLC	507,853	$2.31M	0.7%	N/A	0.265%
11/12/2025	Intech Investment Management LLC	47,489	$216K	0.0%	-37.4%	0.025%
11/10/2025	Ameritas Investment Partners Inc.	12,648	$57K	0.0%	-18.2%	0.007%

ABUS Institutional Ownership - Frequently Asked Questions

During the previous two years, 138 institutional investors and hedge funds held shares of Arbutus Biopharma. The most heavily invested institutionals were Morgan Stanley ($128.44M), Two Seas Capital LP ($60.55M), Whitefort Capital Management LP ($43.30M), Vanguard Group Inc. ($40.82M), Rubric Capital Management LP ($29.82M), State Street Corp ($28.42M), and Adage Capital Partners GP L.L.C. ($20.88M).Learn more on Arbutus Biopharma's institutional investors.

43.79% of Arbutus Biopharma's stock is owned by institutional investors. Learn more on ABUS's institutional investor holdings.

Of the 119 institutional investors that purchased Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rubric Capital Management LP ($6.73M), Two Seas Capital LP ($4.56M), State Street Corp ($3.28M), Goldman Sachs Group Inc. ($3.09M), ADAR1 Capital Management LLC ($2.91M), Morgan Stanley ($2.25M), and Woodline Partners LP ($1.99M).

Institutional investors have bought a total of 24,331,119 shares in the last 24 months. This purchase volume represents approximately $105.19M in transactions.

Of the 46 institutional investors that sold Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ADAR1 Capital Management LLC ($2.28M), Goldman Sachs Group Inc. ($1.43M), Hudson Bay Capital Management LP ($851.80K), Rangeley Capital LLC ($824K), Adage Capital Partners GP L.L.C. ($675K), Foursixthree Capital LP ($578.39K), and JPMorgan Chase & Co. ($452.55K).

Institutional investors have sold a total of 9,383,132 shares in the last 24 months. This volume of shares sold represents approximately $40.58M in transactions.

Related Companies

This page (NASDAQ:ABUS) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arbutus Biopharma (ABUS) Institutional Ownership

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

ABUS Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Arbutus Biopharma (ABUS) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Arbutus Biopharma (NASDAQ:ABUS)

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

ABUS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ABUS shares?

What percentage of Arbutus Biopharma's stock is owned by institutional investors?

Which institutional investors have been buying Arbutus Biopharma's stock?

How much institutional buying is happening at Arbutus Biopharma?

Which of Arbutus Biopharma's major shareholders have been selling company stock?

How much institutional selling is happening at Arbutus Biopharma?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools